You are here

  • Home
  • Archive
  • Volume 19, Issue 3
  • Percutaneous coronary intervention of culprit and non-culprit coronary arteries in acute ST-elevation MI may improve outcomes

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Percutaneous coronary intervention of culprit and non-culprit coronary arteries in acute ST-elevation MI may improve outcomes
  1. Stuart H Chen,
  2. Anjan K Chakrabarti
  1. Department of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
  1. Correspondence to : Dr Stuart H Chen, Department of Cardiology, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Baker 4, Boston MA 02215, USA; shchen{at}bidmc.harvard.edu

http://dx.doi.org/10.1136/eb-2013-101618

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Wald DS, Morris JK, Wald NJ, et al. Randomised trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013;369:1115–23.OpenUrlCrossRefPubMedWeb of Science

    Context

    The paramount goal of the treatment for acute ST-elevation myocardial infarction (STEMI) is the emergent restoration of blood flow through percutaneous coronary intervention (PCI) of the infarct-related or ‘culprit artery’, generally identified as an occluded vessel from a thrombotic lesion. However, multivessel coronary artery disease (CAD) is frequently present in patients with STEMI and portends a worse prognosis.

    The optimal revascularisation strategy for non-culprit coronary lesions in STEMI is unclear.1 The current American College of Cardiology Foundation/American Heart Association and European Society of Cardiology guidelines advise against PCI of non-infarct vessels in the acute setting unless haemodynamic compromise is present, owing to a lack of evidence for its benefit in …

    View Full Text

    Footnotes

    • Competing interests None.